Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4876 to 4890 of 7689 results

  1. Polysomnography:- Does treating obstructive sleep apnoea perioperatively improve outcomes?

    Recommendation ID NG45/2 Question Polysomnography:- Does treating obstructive sleep apnoea perioperatively improve outcomes? Any

    Research recommendation
    Published
    4 May 2016

  2. Predictive accuracy of the PARCA-R for children born preterm:- What is the accuracy of the parent-completed Parent Report of Children's Abilities – Revised(PARCA-R) questionnaire carried out at age 2 years (corrected) for predicting learning disability (intellectual disability), language impairment and special educational needs at age 4 years (uncorrected) for children born preterm?

    Recommendation ID NG72/2 Question Predictive accuracy of the PARCA-R for children born preterm:- What is the accuracy of the parent-completed

    Research recommendation
    Published
    15 October 2018

  3. Are digital and mobile health behaviour change interventions as effective as face-to-face, standard care, or combination approaches for some populations?

    Recommendation ID NG183/4 Question Are digital and mobile health behaviour change interventions as effective as face-to-face, standard

    Research recommendation
    Published
    26 October 2020

  4. Predictive accuracy of the WPPSI-IV at age 4 years (uncorrected) for children born preterm:- What is the accuracy of a Wechsler Preschool and Primary Scale of Intelligence 4th Edition (WPPSI-IV) assessment at age 4 years (uncorrected) for predicting later educational difficulties in children of primary school age who were born before 28+0 weeks' gestation?

    Recommendation ID NG72/1 Question Predictive accuracy of the WPPSI-IV at age 4 years (uncorrected) for children born preterm:- What is

    Research recommendation
    Published
    15 October 2018

  5. Post-operative cell salvage for patients having cardiac surgery with a significant risk of post-operative blood loss:- For patients having cardiac surgery with a significant risk of post-operative blood loss, is post-operative cell salvage and reinfusion clinically and cost effective in reducing red blood cell use and improving clinical outcomes,  compared with existing practice?

    Recommendation ID NG24/3 Question Post-operative cell salvage for patients having cardiac surgery with a significant risk of post-operative

    Research recommendation
    Published
    11 December 2015

  6. Predictors of acute physical risk:- What clinical and biochemical markers are the best predictors of acute physical risk for people with eating disorders?

    Recommendation ID NG69/3 Question Predictors of acute physical risk:- What clinical and biochemical markers are the best predictors of

    Research recommendation
    Published
    12 October 2018

  7. Post-operative weight-bearing in people with ankle fractures:- What is the most clinically effective and cost-effective strategy for weight-bearing in people who have had surgery for internal fixation of an ankle fracture?

    Recommendation ID NG38/4 Question Post-operative weight-bearing in people with ankle fractures:- What is the most clinically effective

    Research recommendation
    Published
    21 March 2016

  8. What are the implications of FH for the safety of a mother during pregnancy and what are the risks of fetal malformations attributable to pharmacological therapies

    Recommendation ID CG71/5 Question What are the implications of FH for the safety of a mother during pregnancy and what are the risks of

    Research recommendation
    Published
    15 November 2019

  9. What is the most effective combination of an analgesic with a neuromuscular blocker, or an analgesic with an anaesthetic agent, for premedication in preterm babies requiring elective or semi-elective intubation?

    Recommendation ID NG124/5 Question What is the most effective combination of an analgesic with a neuromuscular blocker, or an analgesic

    Research recommendation
    Published
    16 August 2019

  10. NICE recommends research generating and analysing observational data including, but not limited to, the existing UK ITP Registry, which collects data on the long-term outcomes of patients treated with eltrombopag and romiplostim.

    Recommendation ID TA293/2 Question NICE recommends research generating and analysing observational data including, but not limited to,

    Research recommendation
    Published
    9 June 2015

  11. [NICE] recommends research into the long-term effects of bisphosphonates on bone quality, given the inhibitory effects on bone resorption of these drugs.

    Recommendation ID TA161/2 Question [NICE] recommends research into the long-term effects of bisphosphonates on bone quality, given the

    Research recommendation
    Published
    9 June 2015

  12. NICE recommends that a national registry is developed to collect data on the use of the RD-100i OSNA system in detecting sentinel lymph node metastases during breast cancer surgery. It also recommends that data on all patients having whole lymph node analysis by the RD-100i OSNA system should be submitted to this registry. These data should be integrated with data from other registries for breast cancer where appropriate.

    Recommendation ID DG8/1 Question NICE recommends that a national registry is developed to collect data on the use of the RD-100i OSNA system

    Research recommendation
    Published
    9 June 2015

  13. NICE recommends that a new model for multiple sclerosis is developed, ideally based on UK patient cohorts, which uses the best available evidence (including experience to date from the risk-sharing scheme) and includes all currently available treatments.

    Recommendation ID TA254/2 Question NICE recommends that a new model for multiple sclerosis is developed, ideally based on UK patient cohorts

    Research recommendation
    Published
    9 June 2015

  14. NICE recommends that studies directly comparing different epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation test methods are performed. These studies should include the re-testing of stored non-small-cell lung cancer (NSCLC) tumour samples using different EGFR-TK mutation test methods and should link to patient outcomes.

    Recommendation ID DG9/1 Question NICE recommends that studies directly comparing different epidermal growth factor receptor tyrosine kinase

    Research recommendation
    Published
    9 June 2015

  15. NICE recommends that further research directly comparing the clinical and cost effectiveness of ranibizumab and bevacizumab in people with diabetic macular oedema should be conducted.

    Recommendation ID TA274/1 Question NICE recommends that further research directly comparing the clinical and cost effectiveness of ranibizumab

    Research recommendation
    Published
    9 June 2015